CLONIDINE HYDROCHLORIDE

CLONIDINE HYDROCHLORIDE was reported 5779 times

CLONIDINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SCHIZENCEPHALY 11 0.2444
1 URINARY TRACT INFECTION NEONATAL 14 0.1918
2 CEREBRAL HAEMORRHAGE FOETAL 11 0.1803
3 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 101 0.1512
4 LUPUS VULGARIS 127 0.1008
5 SERONEGATIVE ARTHRITIS 115 0.1003
6 TEMPERATURE REGULATION DISORDER 169 0.0758
7 RETINITIS 122 0.0706
8 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 125 0.0603
9 DEEP VEIN THROMBOSIS POSTOPERATIVE 120 0.0599
10 WITHDRAWAL HYPERTENSION 12 0.0594
11 DISLOCATION OF VERTEBRA 126 0.0552
12 VASCULAR STENOSIS 18 0.0523
13 FOOD ALLERGY 267 0.0346
14 SWOLLEN JOINT COUNT INCREASED 110 0.0345
15 BONE EROSION 115 0.0325
16 FOETAL DEATH 159 0.0306
17 GENITAL EROSION 9 0.0303
18 RHEUMATIC FEVER 123 0.0276
19 HYPERCHOLESTEROLAEMIA 224 0.0232
20 SWOLLEN JOINT COUNT 5 0.0200
21 RHEUMATOID FACTOR POSITIVE 114 0.0197
22 PRESCRIBED OVERDOSE 374 0.0193
23 IMMUNODEFICIENCY 275 0.0184
24 JOINT DISLOCATION 192 0.0181
25 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 10 0.0178
26 WALKING AID USER 117 0.0177
27 GRIP STRENGTH DECREASED 152 0.0173
28 HELICOBACTER INFECTION 177 0.0172
29 WOUND INFECTION 185 0.0169
30 DUODENAL ULCER PERFORATION 125 0.0168
31 MUSCLE INJURY 133 0.0160
32 SPINAL FUSION SURGERY 65 0.0160
33 SPONDYLITIS 58 0.0159
34 SHORT-BOWEL SYNDROME 10 0.0154
35 COELIAC DISEASE 147 0.0150
36 BURSITIS 175 0.0144
37 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 103 0.0144
38 LUPUS-LIKE SYNDROME 127 0.0140
39 JOINT RANGE OF MOTION DECREASED 186 0.0139
40 EXOSTOSIS 123 0.0135
41 PEMPHIGUS 165 0.0132
42 FOLLICULITIS 136 0.0130
43 AUTOIMMUNE DISORDER 124 0.0127
44 BREAST CANCER STAGE III 82 0.0126
45 STEROID DIABETES 18 0.0120
46 HAND DEFORMITY 157 0.0120
47 HYPERTENSIVE ENCEPHALOPATHY 7 0.0118
48 FOOT DEFORMITY 125 0.0113
49 RED BLOOD CELL SEDIMENTATION RATE INCREASED 120 0.0108
50 ADRENAL NEOPLASM 5 0.0107
51 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 11 0.0104
52 ENTHESOPATHY 16 0.0102
53 PERICARDITIS 171 0.0102
54 MUCOSAL EROSION 9 0.0099
55 C-REACTIVE PROTEIN 9 0.0097
56 HIP ARTHROPLASTY 148 0.0097
57 CARDIOVASCULAR INSUFFICIENCY 15 0.0092
58 HYPERPARATHYROIDISM SECONDARY 23 0.0092
59 IRRITABLE BOWEL SYNDROME 195 0.0091
60 NEPHROGENIC ANAEMIA 42 0.0091
61 PRESCRIBED UNDERDOSE 179 0.0090
62 BREAST DISORDER 18 0.0088
63 INFUSION SITE DISCHARGE 15 0.0085
64 FIBROMYALGIA 198 0.0081
65 HEPATIC CIRRHOSIS 149 0.0079
66 UPPER RESPIRATORY TRACT INFECTION 362 0.0078
67 JOINT STIFFNESS 202 0.0077
68 PORPHYRIA ACUTE 11 0.0077
69 HYPERTENSIVE EMERGENCY 9 0.0076
70 CROUP INFECTIOUS 6 0.0076
71 SCIATICA 120 0.0075
72 SIMPLE PARTIAL SEIZURES 6 0.0074
73 GLOSSODYNIA 165 0.0074
74 X-RAY ABNORMAL 13 0.0073
75 RED BLOOD CELLS URINE POSITIVE 7 0.0072
76 BLOOD PRESSURE DIASTOLIC ABNORMAL 18 0.0071
77 SYNOVITIS 125 0.0069
78 SMALL INTESTINAL RESECTION 8 0.0069
79 LOWER LIMB FRACTURE 130 0.0068
80 WOUND 187 0.0067
81 PULMONARY FIBROSIS 128 0.0067
82 INFUSION RELATED REACTION 442 0.0067
83 CONTRAINDICATED PRODUCT ADMINISTERED 199 0.0066
84 KNEE ARTHROPLASTY 137 0.0065
85 HEPATIC ENZYME INCREASED 437 0.0064
86 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 41 0.0063
87 IMPAIRED HEALING 205 0.0062
88 PRODUCT ADMINISTRATION INTERRUPTED 49 0.0062
89 TYPE 2 DIABETES MELLITUS 208 0.0062
90 LIVER FUNCTION TEST INCREASED 130 0.0060
91 DRUG TOLERANCE DECREASED 17 0.0060
92 LIVER INJURY 144 0.0059
93 EAR INFECTION 152 0.0057
94 TENOSYNOVITIS 15 0.0054
95 DECREASED IMMUNE RESPONSIVENESS 53 0.0054
96 FACET JOINT SYNDROME 17 0.0052
97 AMYLOIDOSIS 9 0.0052
98 DISABILITY 97 0.0049
99 TOOTH EROSION 6 0.0049
100 INFUSION SITE DISCOMFORT 5 0.0048
101 ALLERGY TO CHEMICALS 6 0.0048
102 APPLICATION SITE SCAR 6 0.0048
103 SYSTOLIC DYSFUNCTION 5 0.0047
104 ALLERGY TO ANIMAL 5 0.0047
105 OSTEOARTHRITIS 199 0.0047
106 ALLERGIC SINUSITIS 4 0.0047
107 INFUSION SITE MASS 5 0.0046
108 INFUSION SITE HAEMORRHAGE 15 0.0046
109 INFUSION SITE PRURITUS 14 0.0044
110 DELIRIUM 153 0.0044
111 PERIPHERAL VENOUS DISEASE 18 0.0044
112 CERUMEN IMPACTION 4 0.0044
113 GAIT INABILITY 146 0.0044
114 INCISIONAL HERNIA 6 0.0043
115 OSTEOPOROSIS 176 0.0043
116 MAST CELL ACTIVATION SYNDROME 6 0.0043
117 INCISION SITE PAIN 5 0.0043
118 INFUSION SITE BRUISING 9 0.0042
119 FINGER DEFORMITY 20 0.0041
120 OBSTRUCTIVE SLEEP APNOEA SYNDROME 6 0.0041
121 INTERCEPTED MEDICATION ERROR 19 0.0041
122 BREAST CANCER STAGE I 38 0.0041
123 SYSTEMIC LUPUS ERYTHEMATOSUS 142 0.0040
124 FLUID RETENTION 203 0.0040
125 REBOUND ACID HYPERSECRETION 12 0.0040
126 URINARY TRACT INFECTION BACTERIAL 10 0.0040
127 END STAGE RENAL DISEASE 72 0.0039
128 EXPOSURE DURING PREGNANCY 245 0.0039
129 INFUSION SITE IRRITATION 5 0.0039
130 DAYDREAMING 6 0.0039
131 JOINT DESTRUCTION 6 0.0039
132 C-REACTIVE PROTEIN INCREASED 140 0.0038
133 PSORIATIC ARTHROPATHY 154 0.0038
134 INFUSION SITE REACTION 11 0.0037
135 DRUG-INDUCED LIVER INJURY 113 0.0036
136 HYPERTENSION 762 0.0036
137 SUSPECTED OFF LABEL USE 16 0.0035
138 DISTRIBUTIVE SHOCK 8 0.0035
139 JOINT SWELLING 426 0.0035
140 OEDEMA 189 0.0035
141 RASH ERYTHEMATOUS 165 0.0034
142 BLOOD PRESSURE INADEQUATELY CONTROLLED 20 0.0033
143 ESSENTIAL HYPERTENSION 6 0.0033
144 WHEEZING 194 0.0033
145 RHEUMATOID ARTHRITIS 363 0.0032
146 ONYCHOMADESIS 13 0.0031
147 BLOOD CHOLESTEROL INCREASED 144 0.0031
148 ROAD TRAFFIC ACCIDENT 128 0.0031
149 INFUSION SITE SWELLING 19 0.0030
150 TREATMENT FAILURE 249 0.0030
151 HYPERSENSITIVITY 549 0.0030
152 ULCER HAEMORRHAGE 20 0.0030
153 EYELID PAIN 6 0.0029
154 LEFT VENTRICULAR FAILURE 10 0.0029
155 DERMATITIS CONTACT 33 0.0029
156 PRE-EXISTING CONDITION IMPROVED 18 0.0029
157 TONGUE DISCOMFORT 12 0.0028
158 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 48 0.0028
159 DRUG INTOLERANCE 271 0.0028
160 STRESS CARDIOMYOPATHY 16 0.0027
161 INFUSION SITE ERYTHEMA 23 0.0027
162 FUNGAL SKIN INFECTION 11 0.0027
163 BLISTER 153 0.0027
164 INTENTIONAL PRODUCT MISUSE 238 0.0027
165 INJURY 189 0.0027
166 ASTHMA 302 0.0027
167 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 127 0.0026
168 INFUSION SITE PAIN 34 0.0026
169 PRODUCT PREPARATION ISSUE 17 0.0026
170 MOBILITY DECREASED 186 0.0026
171 BLOOD PRESSURE DIASTOLIC DECREASED 19 0.0026
172 LIP DRY 23 0.0025
173 COSTOCHONDRITIS 4 0.0025
174 INFECTION 355 0.0025
175 ARTHROPATHY 135 0.0024
176 DEVICE INFUSION ISSUE 6 0.0024
177 COMA SCALE ABNORMAL 7 0.0024
178 HYPERHIDROSIS 309 0.0024
179 BLEPHAROSPASM 15 0.0024
180 URINARY BLADDER HAEMORRHAGE 5 0.0024
181 ATTENTION DEFICIT HYPERACTIVITY DISORDER 10 0.0024
182 PSORIASIS 308 0.0024
183 C-REACTIVE PROTEIN ABNORMAL 15 0.0023
184 CERVICAL SPINAL STENOSIS 4 0.0023
185 BLOOD CHLORIDE INCREASED 4 0.0023
186 ONYCHOMYCOSIS 10 0.0023
187 STOMATITIS 137 0.0023
188 PROTEIN TOTAL INCREASED 6 0.0023
189 ARTERIOSPASM CORONARY 9 0.0022
190 RESPIRATORY RATE DECREASED 7 0.0022
191 AMNESIA 144 0.0022
192 SEASONAL ALLERGY 31 0.0022
193 NAIL DISORDER 19 0.0022
194 EOSINOPHILIC OESOPHAGITIS 6 0.0022
195 INFUSION SITE INFECTION 5 0.0021
196 INCORRECT DRUG ADMINISTRATION RATE 9 0.0021
197 LEFT VENTRICULAR HYPERTROPHY 9 0.0021
198 ANXIETY DISORDER 7 0.0021
199 OXYGEN CONSUMPTION INCREASED 5 0.0021
200 RETCHING 44 0.0021
201 RHINOVIRUS INFECTION 8 0.0021
202 MUSCULOSKELETAL STIFFNESS 180 0.0021
203 BLOOD PRESSURE FLUCTUATION 49 0.0020
204 PUSTULAR PSORIASIS 7 0.0020
205 COVID-19 PNEUMONIA 24 0.0020
206 LIVE BIRTH 17 0.0020
207 DISCOMFORT 123 0.0020
208 CONTUSION 194 0.0020
209 BRONCHITIS 148 0.0020
210 HYPERTENSIVE CRISIS 22 0.0020
211 SPINAL STENOSIS 8 0.0019
212 ATRIAL THROMBOSIS 4 0.0019
213 EMBOLISM 16 0.0019
214 MULTIPLE ALLERGIES 15 0.0019
215 SINUSITIS 196 0.0019
216 TOXIC EPIDERMAL NECROLYSIS 29 0.0019
217 INSURANCE ISSUE 29 0.0019
218 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 18 0.0019
219 BLOOD POTASSIUM ABNORMAL 5 0.0019
220 PRODUCT USE ISSUE 352 0.0019
221 DRUG SPECIFIC ANTIBODY PRESENT 12 0.0018
222 CHRONIC KIDNEY DISEASE 139 0.0018
223 CLAVICLE FRACTURE 7 0.0018
224 OBESITY 29 0.0018
225 ARTHRITIS 143 0.0018
226 HYPOAESTHESIA 272 0.0018
227 DRUG TOLERANCE 9 0.0018
228 VASCULAR DEVICE INFECTION 8 0.0018
229 SINUS BRADYCARDIA 17 0.0018
230 BRADYCARDIA 93 0.0018
231 MIOSIS 14 0.0017
232 BLOOD MAGNESIUM DECREASED 15 0.0017
233 KIDNEY INFECTION 34 0.0017
234 HYPERTONIC BLADDER 5 0.0017
235 HOMICIDAL IDEATION 7 0.0017
236 OEDEMA PERIPHERAL 207 0.0017
237 TACHYPNOEA 23 0.0017
238 NODULE 22 0.0017
239 SKIN WEEPING 6 0.0017
240 SEDATION 44 0.0017
241 VISUAL IMPAIRMENT 208 0.0017
242 MYOSITIS 15 0.0017
243 INTENTIONAL PRODUCT USE ISSUE 146 0.0017
244 TACHYCARDIA 148 0.0017
245 ACUTE RESPIRATORY FAILURE 32 0.0017
246 MUSCULAR WEAKNESS 189 0.0017
247 MIXED LIVER INJURY 5 0.0017
248 BLOOD PRESSURE ABNORMAL 33 0.0017
249 RASH VESICULAR 8 0.0017
250 EYE INJURY 5 0.0016
251 BLOOD ALBUMIN DECREASED 13 0.0016
252 GENERAL PHYSICAL HEALTH DETERIORATION 188 0.0016
253 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 11 0.0016
254 PRODUCT DISTRIBUTION ISSUE 15 0.0016
255 PERIPHERAL SWELLING 248 0.0016
256 SNORING 6 0.0016
257 SWELLING 147 0.0016
258 COMMUNICATION DISORDER 6 0.0016
259 SKIN LACERATION 17 0.0016
260 BACK INJURY 17 0.0016
261 GASTROENTERITIS VIRAL 28 0.0015
262 SLEEP DISORDER 108 0.0015
263 DYSPEPSIA 149 0.0015
264 MENTAL STATUS CHANGES 42 0.0015
265 OVERDOSE 324 0.0015
266 POST-TRAUMATIC STRESS DISORDER 10 0.0015
267 HEREDITARY ANGIOEDEMA 16 0.0015
268 PULSE ABSENT 7 0.0015
269 THROMBOCYTOPENIA 164 0.0015
270 CLONUS 4 0.0015
271 AORTIC STENOSIS 5 0.0014
272 NASOPHARYNGITIS 264 0.0014
273 BLOOD PRESSURE INCREASED 218 0.0014
274 SCRATCH 15 0.0014
275 APPLICATION SITE BURN 7 0.0014
276 HYPERVOLAEMIA 7 0.0014
277 BUNDLE BRANCH BLOCK LEFT 6 0.0014
278 INTERVERTEBRAL DISC DEGENERATION 13 0.0014
279 PROTEIN URINE PRESENT 7 0.0014
280 PHARYNGITIS STREPTOCOCCAL 15 0.0014
281 ENCEPHALOPATHY 34 0.0014
282 TASTE DISORDER 28 0.0014
283 PRODUCT LABEL CONFUSION 8 0.0014
284 SENSITIVE SKIN 10 0.0014
285 BLOOD CREATINE INCREASED 6 0.0014
286 ARTHROPOD BITE 10 0.0013
287 CREPITATIONS 4 0.0013
288 ATYPICAL PNEUMONIA 4 0.0013
289 MATERNAL EXPOSURE TIMING UNSPECIFIED 5 0.0013
290 CENTRAL VENOUS CATHETERISATION 4 0.0013
291 CONSTIPATION 289 0.0013
292 BREAST CANCER STAGE II 11 0.0013
293 CRANIOCEREBRAL INJURY 4 0.0013
294 IMPAIRED GASTRIC EMPTYING 18 0.0013
295 ABDOMINAL DISCOMFORT 220 0.0013
296 GASTRIC INFECTION 5 0.0013
297 URTICARIA 218 0.0013
298 LOWER RESPIRATORY TRACT INFECTION 59 0.0013
299 LOCALISED OEDEMA 6 0.0013
300 WEIGHT INCREASED 290 0.0013
301 NEPHROPATHY 12 0.0013
302 CARDIAC MURMUR 11 0.0013
303 VULVOVAGINAL MYCOTIC INFECTION 5 0.0013
304 HAND FRACTURE 9 0.0013
305 SPINAL DISORDER 12 0.0013
306 INITIAL INSOMNIA 13 0.0013
307 BRAIN OEDEMA 16 0.0013
308 STREPTOCOCCAL INFECTION 7 0.0013
309 SLEEP APNOEA SYNDROME 24 0.0013
310 SCREAMING 8 0.0013
311 MEMORY IMPAIRMENT 171 0.0012
312 WEIGHT FLUCTUATION 13 0.0012
313 PERIORBITAL SWELLING 7 0.0012
314 ENURESIS 5 0.0012
315 BLOOD POTASSIUM INCREASED 20 0.0012
316 BACK DISORDER 20 0.0012
317 INTENTIONAL DOSE OMISSION 35 0.0012
318 CYSTITIS 39 0.0012
319 ARTHRITIS BACTERIAL 5 0.0012
320 SKIN HAEMORRHAGE 18 0.0012
321 FOOT OPERATION 6 0.0012
322 DIABETIC NEUROPATHY 6 0.0012
323 ABDOMINAL TENDERNESS 6 0.0012
324 HYDRONEPHROSIS 9 0.0012
325 GENERAL SYMPTOM 9 0.0012
326 PULSELESS ELECTRICAL ACTIVITY 5 0.0012
327 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 85 0.0012
328 COLITIS ISCHAEMIC 8 0.0012
329 WEIGHT DECREASED 329 0.0012
330 RENAL FAILURE CHRONIC 9 0.0012
331 SHOULDER OPERATION 5 0.0012
332 TEMPERATURE INTOLERANCE 12 0.0012
333 BENIGN PROSTATIC HYPERPLASIA 6 0.0012
334 POISONING DELIBERATE 11 0.0012
335 SKIN INFECTION 13 0.0012
336 LYMPHOEDEMA 8 0.0012
337 HORDEOLUM 5 0.0012
338 RESPIRATORY TRACT INFECTION 30 0.0012
339 RESPIRATORY SYNCYTIAL VIRUS INFECTION 10 0.0011
340 CHEST PAIN 212 0.0011
341 POLYARTHRITIS 6 0.0011
342 HEADACHE 712 0.0011
343 VITAMIN D DEFICIENCY 11 0.0011
344 INFUSION SITE EXTRAVASATION 7 0.0011
345 PHARYNGEAL SWELLING 11 0.0011
346 RENAL TUBULAR NECROSIS 11 0.0011
347 IMPLANT SITE PAIN 5 0.0011
348 ANAL ABSCESS 6 0.0011
349 HEART RATE DECREASED 39 0.0011
350 SINUS CONGESTION 15 0.0011
351 RENAL FAILURE 146 0.0011
352 DRY MOUTH 89 0.0011
353 THERAPEUTIC PRODUCT EFFECT DELAYED 5 0.0011
354 MAJOR DEPRESSION 8 0.0011
355 BACK PAIN 254 0.0011
356 TOOTH FRACTURE 12 0.0011
357 GENERALISED TONIC-CLONIC SEIZURE 18 0.0011
358 DRY THROAT 11 0.0011
359 GAIT DISTURBANCE 207 0.0011
360 DECREASED APPETITE 251 0.0011
361 CONJUNCTIVITIS 20 0.0011
362 UMBILICAL HERNIA 5 0.0011
363 SOMNAMBULISM 7 0.0011
364 CANDIDA INFECTION 18 0.0011
365 ERYTHEMA 219 0.0011
366 SEIZURE 123 0.0011
367 SKIN TIGHTNESS 5 0.0011
368 EYE INFECTION 12 0.0011
369 ALOPECIA 208 0.0011
370 PYREXIA 364 0.0011
371 RENAL INJURY 31 0.0010
372 PAIN 641 0.0010
373 MOUTH SWELLING 6 0.0010
374 POSTOPERATIVE WOUND INFECTION 7 0.0010
375 WRONG PRODUCT ADMINISTERED 7 0.0010
376 APHTHOUS ULCER 8 0.0010
377 ILLNESS 106 0.0010
378 APNOEA 8 0.0010
379 ORAL PAIN 23 0.0010
380 CONFUSIONAL STATE 166 0.0010
381 SPINAL OSTEOARTHRITIS 9 0.0010
382 BRAIN FOG 16 0.0010
383 LEUKOPENIA 51 0.0010
384 RESPIRATION ABNORMAL 7 0.0010
385 DROOLING 7 0.0010
386 BIPOLAR DISORDER 11 0.0010
387 EYE PAIN 57 0.0010
388 RESPIRATORY TRACT CONGESTION 16 0.0010
389 HYPOTENSION 202 0.0010
390 GOUT 18 0.0010
391 MOUTH ULCERATION 21 0.0010
392 KLEBSIELLA INFECTION 5 0.0010
393 OSTEOPENIA 15 0.0010
394 DIALYSIS 14 0.0010
395 EPILEPSY 30 0.0010
396 DEPRESSION 223 0.0010
397 CARDIOMEGALY 12 0.0010
398 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 5 0.0010
399 CEREBRAL ISCHAEMIA 5 0.0010
400 HYPOTHYROIDISM 31 0.0010
401 THERAPEUTIC RESPONSE SHORTENED 32 0.0010
402 CHOLECYSTECTOMY 11 0.0010
403 ABORTION INDUCED 9 0.0010
404 BLOOD SODIUM DECREASED 18 0.0010
405 RASH 415 0.0010
406 PROTEINURIA 18 0.0009
407 HYPERSOMNIA 27 0.0009
408 PAIN IN EXTREMITY 276 0.0009
409 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 16 0.0009
410 NIGHT SWEATS 30 0.0009
411 PRODUCT DOSE OMISSION ISSUE 273 0.0009
412 BRUXISM 5 0.0009
413 BEHAVIOUR DISORDER 5 0.0009
414 BLOOD PRESSURE SYSTOLIC INCREASED 18 0.0009
415 SKIN SWELLING 8 0.0009
416 THERAPEUTIC PRODUCT EFFECT DECREASED 41 0.0009
417 DISSOCIATION 7 0.0009
418 LIGAMENT SPRAIN 9 0.0009
419 MATERNAL EXPOSURE DURING PREGNANCY 81 0.0009
420 OXYGEN SATURATION DECREASED 51 0.0009
421 ANXIETY 258 0.0009
422 HYPOTONIA 9 0.0009
423 HALLUCINATION, VISUAL 19 0.0009
424 FOOT FRACTURE 17 0.0009
425 HEART RATE ABNORMAL 5 0.0009
426 GASTROINTESTINAL INFECTION 8 0.0009
427 ELECTROCARDIOGRAM ABNORMAL 7 0.0009
428 PRODUCT LEAKAGE 5 0.0009
429 ACUTE PULMONARY OEDEMA 5 0.0009
430 OCULAR DISCOMFORT 10 0.0009
431 PNEUMONIA 288 0.0009
432 ANAL INCONTINENCE 8 0.0009
433 HYPOTHERMIA 9 0.0009
434 RENAL CYST 7 0.0009
435 TRICUSPID VALVE INCOMPETENCE 7 0.0009
436 NEUTROPHIL COUNT INCREASED 9 0.0009
437 DRUG EFFECT LESS THAN EXPECTED 13 0.0009
438 ECCHYMOSIS 6 0.0009
439 URINARY TRACT INFECTION 149 0.0009
440 OBSESSIVE-COMPULSIVE DISORDER 7 0.0009
441 POOR VENOUS ACCESS 9 0.0009
442 GASTROOESOPHAGEAL REFLUX DISEASE 68 0.0008
443 SPUTUM DISCOLOURED 8 0.0008
444 BLOOD IRON DECREASED 10 0.0008
445 BODY HEIGHT DECREASED 9 0.0008
446 PRODUCT SUPPLY ISSUE 6 0.0008
447 PRODUCT AVAILABILITY ISSUE 19 0.0008
448 DECREASED ACTIVITY 9 0.0008
449 BLOOD PRESSURE DECREASED 55 0.0008
450 FATIGUE 635 0.0008
451 VITREOUS FLOATERS 8 0.0008
452 DENTAL CARIES 9 0.0008
453 SPINAL OPERATION 10 0.0008
454 BREATH SOUNDS ABNORMAL 4 0.0008
455 DEPRESSED LEVEL OF CONSCIOUSNESS 32 0.0008
456 BLADDER DISORDER 8 0.0008
457 APPLICATION SITE SWELLING 4 0.0008
458 RESPIRATORY DISORDER 24 0.0008
459 BRAIN INJURY 8 0.0008
460 CONDITION AGGRAVATED 242 0.0008
461 HYPOXIA 28 0.0008
462 OFF LABEL USE 695 0.0008
463 ACCIDENTAL OVERDOSE 29 0.0008
464 POOR QUALITY SLEEP 17 0.0008
465 HAEMODYNAMIC INSTABILITY 6 0.0008
466 HYPERTHERMIA 6 0.0008
467 ACIDOSIS 6 0.0008
468 WHITE BLOOD CELL COUNT ABNORMAL 5 0.0008
469 ENTERITIS 5 0.0008
470 PRURITUS 299 0.0008
471 URINARY INCONTINENCE 23 0.0008
472 ATRIOVENTRICULAR BLOCK 6 0.0008
473 OROPHARYNGEAL DISCOMFORT 7 0.0008
474 OSTEOMYELITIS 14 0.0008
475 EAR PAIN 15 0.0008
476 PARALYSIS 11 0.0008
477 HAEMORRHAGIC STROKE 6 0.0008
478 VOMITING 360 0.0008
479 BLOOD POTASSIUM DECREASED 23 0.0008
480 CATATONIA 4 0.0008
481 BLOOD LACTIC ACID INCREASED 4 0.0008
482 PULMONARY CONGESTION 10 0.0008
483 IRON DEFICIENCY ANAEMIA 7 0.0008
484 THERAPY NON-RESPONDER 34 0.0008
485 MYOCLONUS 9 0.0008
486 ACUTE KIDNEY INJURY 115 0.0008
487 MENINGITIS 5 0.0007
488 SPINAL FRACTURE 15 0.0007
489 HYPONATRAEMIA 42 0.0007
490 PHOTOPHOBIA 14 0.0007
491 COVID-19 130 0.0007
492 NEURALGIA 18 0.0007
493 PRODUCT TASTE ABNORMAL 10 0.0007
494 PRODUCT PRESCRIBING ISSUE 16 0.0007
495 PRODUCT USE IN UNAPPROVED INDICATION 182 0.0007
496 INSOMNIA 195 0.0007
497 AUTISM SPECTRUM DISORDER 4 0.0007
498 VIRAL INFECTION 24 0.0007
499 COMPLETED SUICIDE 60 0.0007
500 HYPERTRANSAMINASAEMIA 5 0.0007
501 INTENTIONAL OVERDOSE 46 0.0007
502 SURGERY 42 0.0007
503 SKIN FISSURES 14 0.0007
504 ADVERSE EVENT 66 0.0007
505 NECK PAIN 40 0.0007
506 PULMONARY OEDEMA 32 0.0007
507 ARTHRALGIA 297 0.0007
508 LUNG DISORDER 35 0.0007
509 ANKLE FRACTURE 11 0.0007
510 HOSPICE CARE 7 0.0007
511 RENAL DISORDER 33 0.0007
512 REBOUND EFFECT 8 0.0007
513 SINUS DISORDER 14 0.0007
514 EATING DISORDER 15 0.0007
515 LOCALISED INFECTION 17 0.0007
516 HOSPITALISATION 108 0.0007
517 JOINT INJURY 15 0.0007
518 MIGRAINE 67 0.0007
519 DIZZINESS 350 0.0007
520 DERMATITIS ATOPIC 37 0.0007
521 PALPITATIONS 82 0.0007
522 PRODUCT CONTAINER ISSUE 6 0.0007
523 UNRESPONSIVE TO STIMULI 18 0.0007
524 ANURIA 6 0.0007
525 TUBULOINTERSTITIAL NEPHRITIS 13 0.0007
526 MUSCLE STRAIN 6 0.0007
527 FAECES DISCOLOURED 15 0.0007
528 ELECTROLYTE IMBALANCE 8 0.0007
529 FAECES SOFT 5 0.0007
530 HEART RATE INCREASED 68 0.0007
531 DYSPNOEA 387 0.0007
532 RIB FRACTURE 14 0.0007
533 LYMPHOCYTE COUNT DECREASED 12 0.0007
534 HEAD DISCOMFORT 12 0.0007
535 WHITE BLOOD CELL COUNT INCREASED 26 0.0007
536 CEREBRAL DISORDER 5 0.0007
537 ILL-DEFINED DISORDER 41 0.0007
538 DYSPHAGIA 64 0.0007
539 HAEMATURIA 23 0.0007
540 GASTROINTESTINAL DISORDER 60 0.0007
541 ADVERSE DRUG REACTION 60 0.0007
542 HEAVY MENSTRUAL BLEEDING 6 0.0007
543 TOOTHACHE 12 0.0007
544 PSYCHOMOTOR HYPERACTIVITY 11 0.0007
545 APPLICATION SITE PRURITUS 15 0.0007
546 ADRENAL INSUFFICIENCY 8 0.0007
547 HIDRADENITIS 6 0.0007
548 HYPERKALAEMIA 23 0.0007
549 SOMNOLENCE 132 0.0007
550 AGITATION 48 0.0007
551 MUSCLE SPASTICITY 8 0.0007
552 GLOMERULAR FILTRATION RATE DECREASED 8 0.0007
553 SKIN CANCER 14 0.0006
554 PREGNANCY 13 0.0006
555 TOXICITY TO VARIOUS AGENTS 109 0.0006
556 THROAT IRRITATION 29 0.0006
557 CONCUSSION 5 0.0006
558 EYE SWELLING 24 0.0006
559 PHARYNGITIS 8 0.0006
560 ACUTE MYOCARDIAL INFARCTION 19 0.0006
561 PULMONARY THROMBOSIS 7 0.0006
562 INFLUENZA 71 0.0006
563 HEAD INJURY 20 0.0006
564 SPEECH DISORDER 33 0.0006
565 HALLUCINATION, AUDITORY 10 0.0006
566 PRODUCTIVE COUGH 30 0.0006
567 SUPRAVENTRICULAR TACHYCARDIA 6 0.0006
568 LIMB INJURY 17 0.0006
569 LETHARGY 36 0.0006
570 TRANSPLANT REJECTION 5 0.0006
571 MYDRIASIS 8 0.0006
572 BLOOD CALCIUM DECREASED 7 0.0006
573 ACUTE RESPIRATORY DISTRESS SYNDROME 11 0.0006
574 STENT PLACEMENT 5 0.0006
575 MYASTHENIA GRAVIS 5 0.0006
576 NEEDLE ISSUE 18 0.0006
577 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 111 0.0006
578 LIMB DISCOMFORT 19 0.0006
579 SCAB 7 0.0006
580 HEPATOMEGALY 6 0.0006
581 RASH PRURITIC 33 0.0006
582 UPPER-AIRWAY COUGH SYNDROME 5 0.0006
583 TOOTH INFECTION 8 0.0006
584 RESTLESS LEGS SYNDROME 11 0.0006
585 NAUSEA 477 0.0006
586 UPPER LIMB FRACTURE 12 0.0006
587 SKIN DISORDER 20 0.0006
588 AGGRESSION 30 0.0006
589 CARDIAC FAILURE 48 0.0006
590 BONE PAIN 35 0.0006
591 MENTAL DISORDER 26 0.0006
592 BLOOD UREA INCREASED 10 0.0006
593 QUALITY OF LIFE DECREASED 8 0.0006
594 FALL 197 0.0006
595 HEPATIC STEATOSIS 11 0.0006
596 SLUGGISHNESS 6 0.0006
597 ACCIDENT 7 0.0006
598 WRIST FRACTURE 7 0.0006
599 PERIPHERAL COLDNESS 8 0.0006
600 SKIN HYPERPIGMENTATION 5 0.0006
601 DYSPHONIA 34 0.0006
602 COUGH 163 0.0006
603 RESPIRATORY ARREST 16 0.0006
604 HYSTERECTOMY 5 0.0006
605 NOCTURIA 7 0.0006
606 ORAL DISCOMFORT 8 0.0006
607 CELLULITIS 29 0.0006
608 ORTHOSTATIC HYPOTENSION 10 0.0006
609 DIARRHOEA 370 0.0006
610 APPLICATION SITE ERYTHEMA 15 0.0006
611 WITHDRAWAL SYNDROME 24 0.0006
612 PRODUCT USE COMPLAINT 9 0.0006
613 CARPAL TUNNEL SYNDROME 8 0.0006
614 RESPIRATORY DEPRESSION 7 0.0006
615 FEELING HOT 35 0.0006
616 HALLUCINATION 43 0.0006
617 LOSS OF CONSCIOUSNESS 73 0.0006
618 HYPERCALCAEMIA 7 0.0006
619 CLOSTRIDIUM DIFFICILE COLITIS 6 0.0006
620 SINUS TACHYCARDIA 8 0.0006
621 BREAST PAIN 6 0.0006
622 NASAL CONGESTION 33 0.0006
623 ABNORMAL BEHAVIOUR 22 0.0006
624 FREQUENT BOWEL MOVEMENTS 15 0.0006
625 DEHYDRATION 74 0.0006
626 COMPLICATION ASSOCIATED WITH DEVICE 8 0.0006
627 NIGHTMARE 19 0.0005
628 OCULAR HYPERAEMIA 26 0.0005
629 COMA 26 0.0005
630 ROTATOR CUFF SYNDROME 7 0.0005
631 RASH MACULAR 19 0.0005
632 INFLAMMATION 28 0.0005
633 HYPOKALAEMIA 25 0.0005
634 HIATUS HERNIA 7 0.0005
635 EXPOSURE VIA SKIN CONTACT 14 0.0005
636 NERVE INJURY 6 0.0005
637 PULMONARY MASS 8 0.0005
638 PLATELET COUNT INCREASED 7 0.0005
639 MALNUTRITION 6 0.0005
640 SNEEZING 12 0.0005
641 THERAPEUTIC RESPONSE UNEXPECTED 24 0.0005
642 IRRITABILITY 32 0.0005
643 DYSPNOEA EXERTIONAL 20 0.0005
644 PRODUCT DOSE OMISSION IN ERROR 15 0.0005
645 MUSCLE SPASMS 97 0.0005
646 SOPOR 7 0.0005
647 ABDOMINAL DISTENSION 55 0.0005
648 BLOOD URINE PRESENT 10 0.0005
649 AORTIC ANEURYSM 4 0.0005
650 NEUROPATHY PERIPHERAL 50 0.0005
651 DEVICE FAILURE 8 0.0005
652 MICTURITION URGENCY 6 0.0005
653 EYE HAEMORRHAGE 7 0.0005
654 DRY SKIN 70 0.0005
655 NEPHROLITHIASIS 24 0.0005
656 PARANOIA 9 0.0005
657 NEOPLASM 6 0.0005
658 MEDICATION ERROR 29 0.0005
659 SKIN EXFOLIATION 44 0.0005
660 RESPIRATORY FAILURE 38 0.0005
661 LIVER DISORDER 23 0.0005
662 MUSCULOSKELETAL CHEST PAIN 8 0.0005
663 EJECTION FRACTION DECREASED 8 0.0005
664 DIABETES MELLITUS 39 0.0005
665 RHINORRHOEA 33 0.0005
666 APPLICATION SITE RASH 7 0.0005
667 ARTERIAL OCCLUSIVE DISEASE 4 0.0005
668 THERAPY CHANGE 5 0.0005
669 ASTHENIA 191 0.0005
670 EYE PRURITUS 17 0.0005
671 NEUROLEPTIC MALIGNANT SYNDROME 6 0.0005
672 BACTERAEMIA 6 0.0005
673 DYSARTHRIA 19 0.0005
674 GALLBLADDER DISORDER 9 0.0005
675 HYPERLIPIDAEMIA 6 0.0005
676 MASS 7 0.0005
677 SALIVARY HYPERSECRETION 5 0.0005
678 NERVOUSNESS 26 0.0005
679 LACRIMATION INCREASED 15 0.0005
680 FULL BLOOD COUNT DECREASED 10 0.0005
681 EMPHYSEMA 5 0.0005
682 ABDOMINAL PAIN UPPER 102 0.0005
683 INTENTIONAL SELF-INJURY 10 0.0005
684 PRODUCT ADMINISTRATION ERROR 10 0.0005
685 ANHEDONIA 13 0.0005
686 GASTRITIS 13 0.0005
687 MUSCLE TIGHTNESS 8 0.0005
688 PRESYNCOPE 12 0.0005
689 UNDERDOSE 36 0.0005
690 PLEURAL EFFUSION 30 0.0005
691 GENERALISED OEDEMA 6 0.0005
692 CYST 6 0.0005
693 HAIR COLOUR CHANGES 6 0.0005
694 MIDDLE INSOMNIA 9 0.0005
695 EYE DISCHARGE 5 0.0005
696 AGEUSIA 12 0.0005
697 FEELING ABNORMAL 115 0.0005
698 MUSCLE TWITCHING 11 0.0005
699 MUSCULOSKELETAL PAIN 25 0.0005
700 FLATULENCE 27 0.0005
701 SWELLING FACE 31 0.0005
702 CARDIAC ARREST 39 0.0005
703 FEELING JITTERY 9 0.0005
704 HEMIPARESIS 8 0.0005
705 RENAL PAIN 5 0.0005
706 METABOLIC ACIDOSIS 15 0.0005
707 SEROTONIN SYNDROME 9 0.0005
708 MUSCULOSKELETAL DISCOMFORT 8 0.0005
709 HYPOAESTHESIA ORAL 7 0.0005
710 DIPLOPIA 12 0.0005
711 SYRINGE ISSUE 8 0.0005
712 SKIN DISCOLOURATION 21 0.0005
713 DRUG WITHDRAWAL SYNDROME 40 0.0005
714 POLLAKIURIA 19 0.0005
715 DISORIENTATION 18 0.0005
716 THYROID DISORDER 7 0.0005
717 OROPHARYNGEAL PAIN 42 0.0005
718 BLOOD TRIGLYCERIDES INCREASED 8 0.0005
719 HERPES ZOSTER 26 0.0005
720 MALAISE 198 0.0005
721 OBSTRUCTIVE AIRWAYS DISORDER 5 0.0004
722 THERAPY INTERRUPTED 32 0.0004
723 TRANSIENT ISCHAEMIC ATTACK 15 0.0004
724 HEART RATE IRREGULAR 10 0.0004
725 ASCITES 13 0.0004
726 BODY TEMPERATURE INCREASED 9 0.0004
727 DRY EYE 22 0.0004
728 IMPAIRED DRIVING ABILITY 5 0.0004
729 BONE DISORDER 8 0.0004
730 TREATMENT NONCOMPLIANCE 24 0.0004
731 INTERNAL HAEMORRHAGE 5 0.0004
732 CORONARY ARTERY OCCLUSION 6 0.0004
733 SKIN LESION 12 0.0004
734 CATARACT 26 0.0004
735 DYSURIA 16 0.0004
736 TOOTH LOSS 9 0.0004
737 DIVERTICULITIS 12 0.0004
738 APHASIA 13 0.0004
739 HEPATITIS 11 0.0004
740 VISION BLURRED 59 0.0004
741 POST PROCEDURAL HAEMORRHAGE 5 0.0004
742 EPISTAXIS 32 0.0004
743 HEPATOCELLULAR INJURY 6 0.0004
744 DEAFNESS 11 0.0004
745 ECZEMA 22 0.0004
746 PRODUCT ADHESION ISSUE 15 0.0004
747 SYNCOPE 42 0.0004
748 ANGINA PECTORIS 12 0.0004
749 HYPOACUSIS 18 0.0004
750 PANCREATITIS 22 0.0004
751 SWOLLEN TONGUE 13 0.0004
752 DEPRESSED MOOD 22 0.0004
753 DRUG INTERACTION 66 0.0004
754 GLAUCOMA 8 0.0004
755 ATELECTASIS 4 0.0004
756 HERNIA 8 0.0004
757 CLOSTRIDIUM DIFFICILE INFECTION 9 0.0004
758 INTERVERTEBRAL DISC PROTRUSION 9 0.0004
759 NO THERAPEUTIC RESPONSE 5 0.0004
760 CARDIAC DISORDER 38 0.0004
761 HAEMATOCRIT DECREASED 8 0.0004
762 ILEUS 5 0.0004
763 DRUG INEFFECTIVE 530 0.0004
764 HAEMORRHAGE INTRACRANIAL 6 0.0004
765 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 22 0.0004
766 DEVICE USE ISSUE 7 0.0004
767 BURNING SENSATION 28 0.0004
768 SECRETION DISCHARGE 5 0.0004
769 RESPIRATORY DISTRESS 11 0.0004
770 TREMOR 66 0.0004
771 THERAPEUTIC RESPONSE DECREASED 24 0.0004
772 MUSCLE ATROPHY 5 0.0004
773 THIRST 7 0.0004
774 INTRAOCULAR PRESSURE INCREASED 5 0.0004
775 ELECTROCARDIOGRAM QT PROLONGED 14 0.0004
776 ABDOMINAL PAIN 90 0.0004
777 NERVOUS SYSTEM DISORDER 12 0.0004
778 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 20 0.0004
779 CHEST DISCOMFORT 39 0.0004
780 ANKYLOSING SPONDYLITIS 5 0.0004
781 BLOOD GLUCOSE ABNORMAL 7 0.0004
782 ADVERSE REACTION 5 0.0004
783 NEOPLASM MALIGNANT 25 0.0004
784 SENSORY DISTURBANCE 6 0.0004
785 CARDIAC FAILURE CONGESTIVE 30 0.0004
786 MALIGNANT MELANOMA 5 0.0004
787 SUICIDAL IDEATION 34 0.0004
788 PAIN OF SKIN 10 0.0004
789 HYPOCALCAEMIA 7 0.0004
790 FRACTURE 7 0.0004
791 PARAESTHESIA 58 0.0004
792 INCREASED APPETITE 7 0.0004
793 ASPIRATION 4 0.0004
794 MULTIPLE FRACTURES 6 0.0004
795 CHOLESTASIS 7 0.0004
796 ABASIA 9 0.0004
797 STAPHYLOCOCCAL INFECTION 12 0.0004
798 SUICIDE ATTEMPT 22 0.0004
799 ANAPHYLACTIC REACTION 20 0.0004
800 LIP SWELLING 12 0.0004
801 PNEUMONIA ASPIRATION 9 0.0004
802 FUNGAL INFECTION 12 0.0004
803 HUNGER 5 0.0004
804 BALANCE DISORDER 31 0.0004
805 SEPSIS 40 0.0004
806 APHONIA 5 0.0004
807 CRYING 13 0.0004
808 RENAL IMPAIRMENT 30 0.0004
809 FLUSHING 36 0.0004
810 DISTURBANCE IN ATTENTION 19 0.0004
811 HYPOPHAGIA 9 0.0004
812 SCAR 6 0.0004
813 SKIN IRRITATION 16 0.0003
814 ANAPHYLACTIC SHOCK 9 0.0003
815 SKIN ULCER 9 0.0003
816 IMPAIRED QUALITY OF LIFE 5 0.0003
817 HAEMATOMA 9 0.0003
818 PULMONARY ARTERIAL HYPERTENSION 5 0.0003
819 UNEVALUABLE EVENT 26 0.0003
820 COGNITIVE DISORDER 16 0.0003
821 DYSSTASIA 10 0.0003
822 HIP FRACTURE 11 0.0003
823 MYALGIA 58 0.0003
824 CARDIOMYOPATHY 5 0.0003
825 PERITONITIS 7 0.0003
826 ATAXIA 4 0.0003
827 COLITIS ULCERATIVE 15 0.0003
828 DIABETIC KETOACIDOSIS 8 0.0003
829 THROAT TIGHTNESS 9 0.0003
830 HOT FLUSH 25 0.0003
831 LEUKOCYTOSIS 6 0.0003
832 EYE IRRITATION 19 0.0003
833 URINARY RETENTION 11 0.0003
834 HYPERGLYCAEMIA 12 0.0003
835 PANIC ATTACK 12 0.0003
836 IMPAIRED WORK ABILITY 7 0.0003
837 TINNITUS 15 0.0003
838 DEVICE RELATED INFECTION 5 0.0003
839 ALTERED STATE OF CONSCIOUSNESS 7 0.0003
840 INCORRECT PRODUCT ADMINISTRATION DURATION 7 0.0003
841 LUNG INFECTION 5 0.0003
842 APPLICATION SITE IRRITATION 4 0.0003
843 PNEUMOTHORAX 5 0.0003
844 ULCER 5 0.0003
845 BLOOD CREATINE PHOSPHOKINASE INCREASED 9 0.0003
846 POST PROCEDURAL COMPLICATION 6 0.0003
847 MOVEMENT DISORDER 10 0.0003
848 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 63 0.0003
849 ERUCTATION 6 0.0003
850 ANAEMIA 59 0.0003
851 HAEMORRHOIDS 6 0.0003
852 ORAL HERPES 6 0.0003
853 CHILLS 36 0.0003
854 BLOOD CREATININE INCREASED 20 0.0003
855 VENTRICULAR TACHYCARDIA 5 0.0003
856 SEPTIC SHOCK 13 0.0003
857 HEPATIC FAILURE 9 0.0003
858 ACUTE HEPATIC FAILURE 4 0.0003
859 PRODUCT PREPARATION ERROR 6 0.0003
860 EMOTIONAL DISORDER 9 0.0003
861 EMOTIONAL DISTRESS 35 0.0003
862 PULMONARY HYPERTENSION 6 0.0003
863 DERMATITIS 6 0.0003
864 DEMENTIA 8 0.0003
865 THROMBOSIS 23 0.0003
866 COLD SWEAT 5 0.0003
867 DIABETES MELLITUS INADEQUATE CONTROL 5 0.0003
868 RED BLOOD CELL COUNT DECREASED 8 0.0003
869 RECTAL HAEMORRHAGE 12 0.0003
870 CARDIOGENIC SHOCK 4 0.0003
871 CEREBROVASCULAR ACCIDENT 47 0.0003
872 ATRIAL FIBRILLATION 27 0.0003
873 ABDOMINAL PAIN LOWER 7 0.0003
874 DRUG ABUSE 23 0.0003
875 CARDIOVASCULAR DISORDER 7 0.0003
876 PRODUCT DISPENSING ERROR 6 0.0003
877 RESTLESSNESS 10 0.0003
878 APPLICATION SITE PAIN 6 0.0003
879 PSYCHOTIC DISORDER 8 0.0003
880 TOOTH DISORDER 6 0.0003
881 THINKING ABNORMAL 5 0.0003
882 CORONARY ARTERY DISEASE 8 0.0003
883 GASTRIC DISORDER 9 0.0003
884 SHOCK 6 0.0003
885 DRUG PRESCRIBING ERROR 5 0.0003
886 RENAL FAILURE ACUTE 11 0.0003
887 DYSTONIA 5 0.0003
888 MOOD ALTERED 7 0.0003
889 BLOOD GLUCOSE INCREASED 48 0.0003
890 PRODUCT PRESCRIBING ERROR 6 0.0003
891 FEELING COLD 7 0.0003
892 CEREBRAL HAEMORRHAGE 9 0.0003
893 HAEMOPTYSIS 7 0.0003
894 ABSCESS 4 0.0003
895 BLOOD GLUCOSE DECREASED 12 0.0002
896 HYPOGLYCAEMIA 12 0.0002
897 FEEDING DISORDER 5 0.0002
898 DYSKINESIA 10 0.0002
899 CHOLELITHIASIS 8 0.0002
900 EYE DISORDER 8 0.0002
901 LIVER FUNCTION TEST ABNORMAL 7 0.0002
902 RHABDOMYOLYSIS 10 0.0002
903 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 17 0.0002
904 INTESTINAL OBSTRUCTION 9 0.0002
905 GLYCOSYLATED HAEMOGLOBIN INCREASED 6 0.0002
906 LABORATORY TEST ABNORMAL 7 0.0002
907 HAEMOGLOBIN DECREASED 24 0.0002
908 ERECTILE DYSFUNCTION 6 0.0002
909 INJECTION SITE PAIN 71 0.0002
910 DRUG DEPENDENCE 37 0.0002
911 DEVICE DISLOCATION 10 0.0002
912 VERTIGO 14 0.0002
913 HAEMORRHAGE 24 0.0002
914 DRUG ADMINISTRATION ERROR 7 0.0002
915 INJECTION SITE BRUISING 18 0.0002
916 HEPATOTOXICITY 5 0.0002
917 ACCIDENTAL EXPOSURE TO PRODUCT 23 0.0002
918 FEAR 6 0.0002
919 JAUNDICE 6 0.0002
920 DRUG EFFECT DECREASED 12 0.0002
921 PANCREATITIS ACUTE 5 0.0002
922 MOOD SWINGS 7 0.0002
923 ABNORMAL DREAMS 6 0.0002
924 PROCEDURAL PAIN 6 0.0002
925 PERICARDIAL EFFUSION 5 0.0002
926 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 5 0.0002
927 WHITE BLOOD CELL COUNT DECREASED 23 0.0002
928 DEATH 181 0.0002
929 PRODUCT SUBSTITUTION ISSUE 12 0.0002
930 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 7 0.0002
931 MENTAL IMPAIRMENT 5 0.0002
932 CHOKING 4 0.0002
933 INJECTION SITE URTICARIA 5 0.0002
934 ANGIOEDEMA 9 0.0002
935 PULMONARY EMBOLISM 19 0.0002
936 HAEMATOCHEZIA 11 0.0002
937 BLINDNESS 8 0.0002
938 INJECTION SITE SWELLING 15 0.0002
939 INJECTION SITE RASH 6 0.0002
940 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 5 0.0002
941 RASH GENERALISED 5 0.0002
942 BONE DENSITY DECREASED 6 0.0002
943 PRODUCT QUALITY ISSUE 26 0.0002
944 CARDIO-RESPIRATORY ARREST 8 0.0002
945 ARRHYTHMIA 9 0.0002
946 MYOCARDIAL INFARCTION 33 0.0002
947 COLITIS 7 0.0002
948 DEVICE LEAKAGE 8 0.0002
949 PNEUMONITIS 5 0.0002
950 DEVICE ISSUE 16 0.0002
951 ANGER 6 0.0002
952 CHROMATURIA 4 0.0002
953 MULTIPLE ORGAN DYSFUNCTION SYNDROME 5 0.0002
954 PAIN IN JAW 5 0.0002
955 MULTIPLE SCLEROSIS RELAPSE 12 0.0002
956 INJECTION SITE REACTION 12 0.0002
957 NEUTROPHIL COUNT DECREASED 7 0.0002
958 PRODUCT STORAGE ERROR 15 0.0002
959 INCORRECT DOSE ADMINISTERED 39 0.0002
960 DEEP VEIN THROMBOSIS 11 0.0002
961 MULTIPLE SCLEROSIS 8 0.0002
962 ALANINE AMINOTRANSFERASE INCREASED 10 0.0002
963 INJECTION SITE MASS 6 0.0002
964 FEMUR FRACTURE 5 0.0002
965 FOETAL EXPOSURE DURING PREGNANCY 13 0.0002
966 NO ADVERSE EVENT 28 0.0002
967 SKIN BURNING SENSATION 11 0.0002
968 ASPARTATE AMINOTRANSFERASE INCREASED 8 0.0002
969 PLATELET COUNT DECREASED 16 0.0001
970 DYSGEUSIA 11 0.0001
971 DISEASE RECURRENCE 7 0.0001
972 LYMPHADENOPATHY 5 0.0001
973 CONVULSION 8 0.0001
974 WRONG TECHNIQUE IN DRUG USAGE PROCESS 5 0.0001
975 DEVICE DIFFICULT TO USE 9 0.0001
976 DRUG DOSE OMISSION 22 0.0001
977 ACNE 10 0.0001
978 GASTROINTESTINAL HAEMORRHAGE 11 0.0001
979 INJECTION SITE ERYTHEMA 16 0.0001
980 EXTRA DOSE ADMINISTERED 5 0.0001
981 INFLUENZA LIKE ILLNESS 10 0.0001
982 INJECTION SITE PRURITUS 8 0.0001
983 DISEASE PROGRESSION 14 0.0001
984 THERAPY CESSATION 6 0.0001
985 VAGINAL HAEMORRHAGE 5 0.0001
986 INJECTION SITE HAEMORRHAGE 9 0.0001
987 PRODUCT DOSE OMISSION 7 0.0001
988 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 5 0.0001
989 RENAL CANCER 5 0.0001
990 DRUG DOSE OMISSION BY DEVICE 7 0.0001
991 MALIGNANT NEOPLASM PROGRESSION 8 0.0001
992 BLADDER CANCER 4 0.0001
993 NEUTROPENIA 9 0.0001
994 BREAST CANCER 5 0.0001